Literature DB >> 8421259

Psychosocial factors and clinical evolution in HIV-1 infection: a longitudinal study.

L Solano1, M Costa, S Salvati, R Coda, F Aiuti, I Mezzaroma, M Bertini.   

Abstract

The aim of the study was to assess the relationship between the initial psychosocial situation and the probability of later symptom development in HIV-1 infection. One hundred HIV-1 seropositive subjects, 79 in Stage III (LAS) and 21 in Stage II (asymptomatic), were examined both immunologically (CD4+, Skin Test) and psychologically (test battery). Follow-up at 6 and 12 months involved clinical and immunological reassessment of subjects, who were then classified as fully symptomatic (S, Stage IV) or unchanged (U). The two groups were compared through ANOVA on initial psychosocial measures, while stepwise logistic multiple regression was employed to assess the predictive value of psychosocial measures on clinical and immunological evolution. Psychosocial measures most clearly showing an association with clinical evolution were Denial/Repression attitudes (negatively) and Fighting Spirit (positively), whereas aspects of Hardiness and Social Support showed an effect in interaction with initial CD4+ levels. No stable results were obtained on immunologic evolution. The two groups (U and S) did not show significant differences on other independent variables, with the exception of age.

Entities:  

Mesh:

Year:  1993        PMID: 8421259     DOI: 10.1016/0022-3999(93)90122-v

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  13 in total

1.  Differences in functional immune responses of high vs. low hardy healthy individuals.

Authors:  C L Dolbier; R R Cocke; J A Leiferman; M A Steinhardt; S J Schapiro; P N Nehete; J E Perlman; J Sastry
Journal:  J Behav Med       Date:  2001-06

2.  Rebooting resilience: shifts toward dynamic, multi-level, and technology-based approaches for people living with HIV.

Authors:  Sayward Harrison; Xiaoming Li
Journal:  AIDS Care       Date:  2019-01-24

3.  Psychological Distress Mediates the Effect of Alexithymia on 2-Year Change in HIV Viral Load.

Authors:  Roger C McIntosh; Gail Ironson; Michael Antoni; Betty Lai; Mahendra Kumar; Mary Ann Fletcher; Neil Schneiderman
Journal:  Int J Behav Med       Date:  2017-04

Review 4.  Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection.

Authors:  J F Sheridan; C Dobbs; D Brown; B Zwilling
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 5.  Resilience and HIV: a review of the definition and study of resilience.

Authors:  Akilah J Dulin; Sannisha K Dale; Valerie A Earnshaw; Joseph L Fava; Michael J Mugavero; Sonia Napravnik; Joseph W Hogan; Michael P Carey; Chanelle J Howe
Journal:  AIDS Care       Date:  2019-01-11

Review 6.  Psychosocial risk and management of physical diseases.

Authors:  Neil Schneiderman; Roger C McIntosh; Michael H Antoni
Journal:  J Behav Med       Date:  2019-01-10

7.  Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.

Authors:  Gail Ironson; Conall O'Cleirigh; Mary Ann Fletcher; Jean Philippe Laurenceau; Elizabeth Balbin; Nancy Klimas; Neil Schneiderman; George Solomon
Journal:  Psychosom Med       Date:  2005 Nov-Dec       Impact factor: 4.312

Review 8.  The effects of depression, stressful life events, social support, and coping on the progression of HIV infection.

Authors:  J Leserman
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 9.  Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence.

Authors:  Gail Ironson; H'Sien Hayward
Journal:  Psychosom Med       Date:  2008-06       Impact factor: 4.312

10.  Does distress tolerance moderate the impact of major life events on psychosocial variables and behaviors important in the management of HIV?

Authors:  Conall O'Cleirigh; Gail Ironson; Jasper A J Smits
Journal:  Behav Ther       Date:  2007-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.